
Frigg Medtech develops the Frigg Surface Scanner, a portable and AI-powered device designed for quick and accurate detection and prevention of pressure ulcers (bedsores). The product offers early detection through multi-sensor biomarker detection, enabling healthcare workers to streamline workflows, reduce risks, and improve patient outcomes. Frigg's solution addresses the limitations of existing manual assessment methods by providing faster, more reliable, and less complex pressure ulcer detection. The company is in the product development phase, targeting certification and market launch in Norway and Europe, and seeks partners and investors to scale its business and impact the healthcare industry positively.

Frigg Medtech develops the Frigg Surface Scanner, a portable and AI-powered device designed for quick and accurate detection and prevention of pressure ulcers (bedsores). The product offers early detection through multi-sensor biomarker detection, enabling healthcare workers to streamline workflows, reduce risks, and improve patient outcomes. Frigg's solution addresses the limitations of existing manual assessment methods by providing faster, more reliable, and less complex pressure ulcer detection. The company is in the product development phase, targeting certification and market launch in Norway and Europe, and seeks partners and investors to scale its business and impact the healthcare industry positively.